Nephrol Dial Transplant Vol. 19 No. 12 © ERA-EDTA 2004; all rights reserved
Original Article
Gabapentin therapy for pruritus in haemodialysis patients: a randomized, placebo-controlled, double-blind trial
1 Department of Nephrology, 2 Department of Neurology and 3 Department of Biochemistry, F
rat University Medical School, Elazi
, Turkey
Correspondence and offprint requests to: Dr Ali
hsan Günal, F
rat Üniversitesi T
p Fakültesi, Nefroloji Bilim Dal
, 23200 Elaz
, Turkey. E-mail: igunal{at}yahoo.com
Background. Uraemic pruritus is a common and distressing symptom in patients on haemodialysis for chronic renal failure. Gabapentin is an anticonvulsant that alleviates neuropathic pain. We conducted a double-blind, placebo-controlled, crossover study to assess its effectiveness against renal itch.
Methods. We enrolled in the trial 25 adult patients on haemodialysis who were asked to daily record the severity of their pruritus on a visual analogue scale. The patients were randomly assigned to receive gabapentin for 4 weeks followed by placebo for 4 weeks or the reverse sequence. Gabapentin or placebo were administered thrice weekly, at the end of haemodialysis sessions.
Results. The mean pruritus score of the cohort before the study was 8.4±0.94. After placebo intake, it decreased to 7.6±2.6 (P = 0.098). The score of four patients decreased by >50% following placebo. After gabapentin administration, the mean score decreased significantly, to 1.2±1.8 (P = 0.0001), although one patient's symptoms did not improve significantly. No patient dropped out of the study due to adverse effects from gabapentin.
Conclusions. Our study shows that gabapentin is safe and effective for treating uraemic pruritus in haemodialysis patients. Our results also support the neuropathic hypothesis of uraemic pruritus.
Keywords: gabapentin; haemodialysis; uraemic pruritus
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
T. Vila, J. Gommer, and A. C Scates Role of Gabapentin in the Treatment of Uremic Pruritus Ann. Pharmacother., July 1, 2008; 42(7): 1080 - 1084. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Sheen, S.-T. Ho, C.-H. Lee, Y.-C. Tsung, and F.-L. Chang Preoperative Gabapentin Prevents Intrathecal Morphine-Induced Pruritus After Orthopedic Surgery Anesth. Analg., June 1, 2008; 106(6): 1868 - 1872. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Manenti and A. Vaglio Gabapentin use in chronic uraemic itch is in line with emerging pathogenetic hypothesis Nephrol. Dial. Transplant., December 1, 2007; 22(12): 3669 - 3670. [Full Text] [PDF] |
||||
![]() |
B. Wikstrom Itchy skin--a clinical problem for haemodialysis patients Nephrol. Dial. Transplant., July 1, 2007; 22(suppl_5): v3 - v7. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. L. Pisoni, B. Wikstrom, S. J. Elder, T. Akizawa, Y. Asano, M. L. Keen, R. Saran, D. C. Mendelssohn, E. W. Young, and F. K. Port Pruritus in haemodialysis patients: international results from the Dialysis Outcomes and Practice Patterns Study (DOPPS) Nephrol. Dial. Transplant., December 1, 2006; 21(12): 3495 - 3505. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Manenti and A. Vaglio Gabapentin for uraemic pruritus Nephrol. Dial. Transplant., June 1, 2005; 20(6): 1278 - 1279. [Full Text] [PDF] |
||||


